Exscientia
rapidly scaling pipeline doing more to learn more projects in progress | Exscientia
Company
Deck Type
Sector
Industry
Deck date
June 2022
Slide
13 of 37
Related slides by other companies
Nuvalent
Investor Presentation
February 2024
pipeline advancing a portfolio of potentially best in class products with complementary initial indications in lead indication product candidate discovery enabling phase phase anticipated milestones rights open enrolling phase portion phase trial data update medical meeting alk open enrolling phase portion phase trial phase initiation data update medical meeting her phase initiation undisclosed targets additional discovery research programs ongoing key milestone achieved planned milestone | Nuvalent
AstraZeneca
Results
November 2024
project movements since update | AstraZeneca
Fusion Pharmaceuticals
Investor Presentation
November 2023
unlocking the potential of in novel targets sey discovery | Fusion Pharmaceuticals
Nuvalent
Investor Presentation
January 2024
pipeline advancing a portfolio of potentially best in class products with complementary initial indications in lead indication product candidate discovery enabling phase phase phase anticipated milestones rights open enrolling phase portion phase trial data update at medical meeting alk open enrolling phase portion phase trial i phase initiation data update at medical meeting her phase initiation undisclosed targets additional discovery research programs ongoing | Nuvalent
Other recent decks by Exscientia
See all presentations (14 decks)
Investor Presentation
March 2024
Results
March 2024
Investor Day
January 2024
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights